Formulation and evaluation of ranolazine extended release tablets: Influence of polymers
Main Article Content
Abstract
of angina in patients who have not achieved an adequate response with other anti-anginal agents. The present investigationwas undertaken to design extended release tablets of Ranolazine employing hypromellose phthalate grade HP-55, ethocel standard 7FP premium ethyl cellulose, Surelease E-7-19040, Klucel HF pharm and Natrosol Type 250 HHX as matrix forming agents using wet granulation method. Formulated tablets were evaluated for uniformity of weight, assay, water content, in vitro drug release studies and stability studies.The drug release followed first order kinetics with both erosion and diffusion as the release mechanism. It is concluded that the desired drug release pattern can be obtained by using natrosol type 250 HHX compared to other polymers. The similarity factor (f2) was calculated to select best formulation by comparing in vitro dissolution data of the commercial formulation Ranexa®. The formulated tablets fulfilled the compendia requirements. The formulated Ranolazine Extended release tablets were found to be stable.
Downloads
Article Details
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
References
Remington. The science and practice of pharmacy. 21st ed. USA:
Lippincott, Williams and Wilkins Publications; 2005. p. 939-64.
Thomson. Physician Desk Reference. 61st ed. Montvale, New Jersey:
Thomson PDR; 2007, p. 1035-37.
Ferrero Rodriguez C, Bruneau N, Barra J, Alfonso D, Doelker E.
Hydrophilic Cellulose derivatives as drug delivery carriers: influence
of substitution type on the properties of compressed matrix tablets,
In: Wise DL, editor Handbook of Pharmaceutical Controlled Release
Technology. New York: Marcel Dekker; 2000. p. 1-30.
Lee PI, Diffusional release of a solute from polymeric matrix-
approximate analytical solutions. Journal of Membrane Science
:7:255-75.
Tiwari S, Rajabi-Siahboomi AR, Extended-release oral drug delivery
technologies: monolithic matrix systems. Drug delivery systems.
Totowa NJ, Jain KK, editors. New York: Humana Press; 2008. p. 217-43.
Vass S, Deng H, Rajabi-Siahboomi AR, Investigation of ethylcellulose in
the preparation of theophylline extended release inert matrix tablets,
AAPS annual meeting and exposition; 2008.
Ruiz NR, Ghaly ES. Mechanism of drug release from matrices prepared
with aqueous dispersion of ethylcellulose. Drug Dev Ind Pharm
:23:113-7.
The United States Pharmacopeia, 34th revision and the National
formulary. 29th ed., vol. 1. The United States Pharmacopeial Convention,
Twinbrook Parkway, MD 20852; 2011. p. 403-6.
The United States Pharmacopeia, 34th revision and the National
formulary. 29th ed., vol. 1. The United States Pharmacopeial Convention,
Twinbrook Parkway, MD 20852; 2011. p. 407-10.
Available from: http://www.accessdatadata.fda.gov/scripts/cder/
dissolution/dsp_searchresults_dissolution. Cfm. [Last accessed on
Jul 19].
A v a i l a b l e f r o m : h t t p : / / w w w. f d a . g o v / d o w n l o a d s / d r u g s /
guidancecomplianceregulatoryinformation/guidances/ ucm201217.
pdf. [Last accessed on 2011 Jul 19].
Kulkarni SV, Kumar PR, Rao BS, Kumar PA, Ramesh B, Pranitha Y,
et al. Preparation and in vitro evaluation of controlled release matrix
tablets of stavudine using natural and synthetic polymers. J Pharm Res
:3:1463-66.